Active Bacterial Core Surveillance of the Emerging Infections Program Network

Abstract

Active Bacterial Core surveillance (ABCs) is a collaboration between the Centers for Disease Control and Prevention and several state health departments and universities participating in the Emerging Infections Program Network. ABCs conducts population-based active surveillance, collects isolates, and performs studies of invasive disease caused by Streptococcus pneumoniae, group A and group B Streptococcus, Neisseria meningitidis, and Haemophilus influenzae for a population of 17 to 30 million. These pathogens caused an estimated 97,000 invasive cases, resulting in 10,000 deaths in the United States in 1998. Incidence rates of these pathogens are described. During 1998, 25% of invasive pneumococcal infections in ABCs areas were not susceptible to penicillin, and 13.3% were not susceptible to three classes of antibiotics. In 1998, early-onset group B streptococcal disease had declined by 65% over the previous 6 years. More information on ABCs is available at www.cdc.gov/ncidod/dbmd/abcs. ABCs specimens will soon be available to researchers through an archive.

References 28

1. 1.

   Adams W. G., Deaver K. A., Cochi S. L., Plikaytis B. D., Zell E. R., Broome C. V., Wenger J. D. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993;269(2):221-226.

   Not in our library

2. 2.

   Beall B., Facklam R., Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol. 1996;34(4):953-958.

   Not in our library10.1128/jcm.34.4.953-958.1996

3. 3.

   Blumberg H. M., Stephens D. S., Modansky M., Erwin M., Elliot J., Facklam R. R., Schuchat A., Baughman W., Farley M. M. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis. 1996;173(2):365-373.

   Not in our library10.1093/infdis/173.2.365

4. 4.

   Centers for Disease Control and Prevention (CDC). Adoption of hospital policies for prevention of perinatal group B streptococcal disease--United States, 1997. MMWR Morb Mortal Wkly Rep. 1998;47(32):665-670.

   Not in our library

5. 5.

   Centers for Disease Control and Prevention (CDC). Foodborne Diseases Active Surveillance Network, 1996. MMWR Morb Mortal Wkly Rep. 1997;46(12):258-261.

   Not in our library

6. 6.

   Centers for Disease Control and Prevention (CDC). Intussusception among recipients of rotavirus vaccine--United States, 1998-1999. MMWR Morb Mortal Wkly Rep. 1999;48(27):577-581.

   Not in our library

7. 7.

   Centers for Disease Control and Prevention (CDC). Laboratory practices for prenatal Group B streptococcal screening and reporting--Connecticut, Georgia, and Minnesota, 1997-1998. MMWR Morb Mortal Wkly Rep. 1999;48(20):426-428.

   Not in our library

8. 8.

   Centers for Disease Control and Prevention (CDC). Surveillance for Creutzfeldt-Jakob disease--United States. MMWR Morb Mortal Wkly Rep. 1996;45(31):665-668.

   Not in our library

9. 9.

   Charles D., Larsen B. Streptococcal puerperal sepsis and obstetric infections: a historical perspective. Rev Infect Dis. 1986;8(3):411-422.

   Not in our library10.1093/clinids/8.3.411

10. 10.

    Chin A. E., Hedberg K., Cieslak P. R., Cassidy M., Stefonek K. R., Fleming D. W. Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method. Emerg Infect Dis. 1999;5(5):688-693.

    Not in our library10.3201/eid0505.990510

11. 11.

    Factor S. H., Whitney C. G., Zywicki S. S., Schuchat A. Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. The Active Bacterial Core Surveillance Team. Obstet Gynecol. 2000;95(3):377-382.

    Not in our library10.1016/s0029-7844(99)00549-9

12. 12.

    Feikin D. R., Schuchat A., Kolczak M., Barrett N. L., Harrison L. H., Lefkowitz L., McGeer A., Farley M. M., Vugia D. J., Lexau C. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health. 2000;90(2):223-229.

    Not in our library10.2105/ajph.90.2.223

13. 13.

    Freedman R. M., Ingram D. L., Gross I., Ehrenkranz R. A., Warshaw J. B., Baltimore R. S. A half century of neonatal sepsis at Yale: 1928 to 1978. Am J Dis Child. 1981;135(2):140-144.

    Not in our library10.1001/archpedi.1981.02130260032010

14. 14.

    Gherardi G., Whitney C. G., Facklam R. R., Beall B. Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles. J Infect Dis. 2000;181(1):216-229.

    Not in our library10.1086/315194

15. 15.

    Harrison L. H., Dwyer D. M., Johnson J. A. Emergence of serotype V group B streptococcal infection among infants and adults. J Infect Dis. 1995;171(2):513-513.

    Not in our library10.1093/infdis/171.2.513

16. 16.

    Klugman K. P. Pneumococcal resistance to antibiotics. Clin Microbiol Rev. 1990;3(2):171-196.

    Not in our library10.1128/cmr.3.2.171

17. 17.

    McCracken G. H. Group B streptococci: the new challenge in neonatal infections. J Pediatr. 1973;82(4):703-706.

    Not in our library10.1016/s0022-3476(73)80603-1

18. 18.

    Mohle-Boetani J. C., Schuchat A., Plikaytis B. D., Smith J. D., Broome C. V. Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis. JAMA. 1993;270(12):1442-1448.

    Not in our library

19. 19.

    Nuorti J. P., Butler J. C., Farley M. M., Harrison L. H., McGeer A., Kolczak M. S., Breiman R. F. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med. 2000;342(10):681-689.

    Not in our library10.1056/nejm200003093421002

20. 20.

    Perkins B. A., Flood J. M., Danila R., Holman R. C., Reingold A. L., Klug L. A., Virata M., Cieslak P. R., Zaki S. R., Pinner R. W. Unexplained deaths due to possibly infectious causes in the United States: defining the problem and designing surveillance and laboratory approaches. The Unexplained Deaths Working Group. Emerg Infect Dis. 1996;2(1):47-53.

    Not in our library10.3201/eid0201.960106

21. 21.

    Pinner R. W., Schuchat A., Swaminathan B., Hayes P. S., Deaver K. A., Weaver R. E., Plikaytis B. D., Reeves M., Broome C. V., Wenger J. D. Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group. JAMA. 1992;267(15):2046-2050.

    Not in our library

22. 22.

    Schrag S. J., Zywicki S., Farley M. M., Reingold A. L., Harrison L. H., Lefkowitz L. B., Hadler J. L., Danila R., Cieslak P. R., Schuchat A. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342(1):15-20.

    Not in our library10.1056/nejm200001063420103

23. 23.

    Schuchat A., Deaver K. A., Wenger J. D., Plikaytis B. D., Mascola L., Pinner R. W., Reingold A. L., Broome C. V. Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria Study Group. JAMA. 1992;267(15):2041-2045.

    Not in our library

24. 24.

    Schuchat A., Robinson K., Wenger J. D., Harrison L. H., Farley M., Reingold A. L., Lefkowitz L., Perkins B. A. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. 1997;337(14):970-976.

    Not in our library10.1056/nejm199710023371404

25. 25.

    Schwartz B., Facklam R. R., Breiman R. F. Changing epidemiology of group A streptococcal infection in the USA. Lancet. 1990;336(8724):1167-1171.

    Not in our library10.1016/0140-6736(90)92777-f

26. 26.

    Swartley J. S., Marfin A. A., Edupuganti S., Liu L. J., Cieslak P., Perkins B., Wenger J. D., Stephens D. S. Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A. 1997;94(1):271-276.

    Not in our library10.1073/pnas.94.1.271

27. 27.

    Wenger J. D., Pierce R., Deaver K. A., Plikaytis B. D., Facklam R. R., Broome C. V. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Haemophilus Influenzae Vaccine Efficacy Study Group. Lancet. 1991;338(8764):395-398.

    Not in our library

28. 28.

    Zangwill K. M., Schuchat A., Wenger J. D. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ. 1992;41(6):25-32.

    Not in our library

Cited by papers we hold 1

• Vaccine Escape Recombinants Emerge after Pneumococcal Vaccination in the United States · 2007
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.